Concepedia

Author

J.M. Tourani

Centre Hospitalier Universitaire de Poitiers

Also Known As

J M Tourani, J-M TOURANI, J-M Tourani, J. M. Tourani, J. Tourani, J.-M. Tourani, J.M. Tourani, Jean-Marc Tourani

50

Publications

1.3K

Citations

18

H-Index

74

Concepts

All Affiliations

Centre Hospitalier Universitaire de PoitiersHôpital LaennecSorbonne UniversitéUniversité de PoitiersPitié-Salpêtrière Hospital
JT

About

J.M. Tourani is an author at Centre Hospitalier Universitaire de Poitiers specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

19

926

2

Health Sciences

5

5

339

3

Natural Sciences

1

1

46

4

Nursing

1

1

14

5

Public Health

1

1

33

J.M. Tourani

×

24

Publications

1.2K

Citations

17

H-Index

YearCitations

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial

Yungan Tao, J. Biau, X.S. Sun,

Annals of Oncology

2022

166

Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanoma.

D. Khayat, Christian Borel, J.M. Tourani,

Journal of Clinical Oncology

1993

149

Elevation of IgE in HIV-infected subjects: A marker of poor prognosis

Dominique Israël‐Biet, François Labrousse, J.M. Tourani,

Journal of Allergy and Clinical Immunology

1992

133

Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study.

D. Machover, L Schwarzenberg, Emma Goldschmidt,

PubMed

1982

117

Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative Group.

J.M. Tourani, C. Pfister, J.F. Berdah,

Journal of Clinical Oncology

1998

78

LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial

Jean Bourhis, Clément Sire, Yungan Tao,

Annals of Oncology

2020

63

HIV-associated non-Hodgkin's lymphomas: Clinical characteristics and outcome. The experience of the French Registry of HIV-associated Tumors*

Sérgio Roithmann, Michel Toledano, J.M. Tourani,

Annals of Oncology

1991

56

Vinflunine – an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study

Jaafar Bennouna, J-L Breton, J.M. Tourani,

British Journal of Cancer

2006

52

Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments

Anthony Tran, Chantal Housset, B Boboc,

Journal of Hepatology

1991

47

The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progression

Aurélie Ferru, Gaëlle Fromont, Hélène Gibelin,

British Journal of Cancer

2006

46

Page 1